GLP-1 Dosing Error Help Card
After a GLP-1 dosing error, enter the medication and injection record to generate a doctor-ready incident summary and clear guidance on where to seek care.
After a GLP-1 drug is injected by mistake, injected twice, or miscalculated during dose conversion, the user enters the medication name, pen strength, concentration, injection time, and approximate dose. The product first reconciles the different units into an incident card that can be handed directly to a doctor or poison center, then flags the urgency of seeking help based on known danger signs.
It does not advise users how to correct the dose themselves. Instead, it turns a confused record into facts a professional can use quickly; the same record can support future injections and reduce repeat mistakes.
Why now
In the 168 hours ending July 19, U.S. search-volume labeling for “glp-1 overdose” reached 100,000+ with 1,000% growth, though the signal had already declined on July 18. This indicates that a concentrated help-seeking moment has just occurred, not market size or sustained demand.
Target user
People who have just realized they may have injected twice, selected the wrong pen strength, or cannot confirm a unit conversion for a compounded vial, and are preparing to contact a doctor, Poison Control, or an emergency department. It also serves caregivers checking packaging and injection records for a family member. The FDA has documented these errors among patients and health care professionals because of concentration and unit conversions. S1
Minimal entry point
The first release covers commonly used injectable GLP-1 medications in the United States. It uses the openFDA Drug Label API to match approved product names and strengths; for compounded vials, users must enter the concentration manually and confirm a package photo. S3 It produces a one-page incident card, flags severe symptoms from official labels, and provides direct routes to webPOISONCONTROL, Poison Control by phone, or the emergency department. It does not derive a “safe dose” on its own. FDA records show that confusion among milligrams, milliliters, and “units,” along with differing compounded concentrations, can lead to errors. S1
Punching above its weight
Create indexable free incident-card pages around high-intent help queries such as “took Ozempic twice” and “semaglutide units to mg mistake,” then offer telehealth prescribers, weight-loss clinics, and compounding pharmacies QR-code entry points for medication instructions or patient portals.
Competitors & gaps
- webPOISONCONTROLGoogle
- It already triages individual cases using the substance, dose, age, weight, symptoms, and time of exposure. This product should not recreate toxicology judgment; it should verify GLP-1-specific brand, pen strength, concentration, and units, then carry the organized facts into the help-seeking flow. S2
- U.S. Poison Control phone serviceGoogle
- Phone support provides direct expert guidance and is free and available around the clock in the United States. The opportunity is to organize package details, injection timing, and estimated dose before the call, so people do not have to make verbal conversions while distressed. S2
How it makes money
Keep the personal event card and help-access links free. Charge telehealth practices, weight-loss clinics, and compounding pharmacies a monthly fee for an institutional version with branded forms, configurable fields, team management, and standardized exports.
The case against
The central risk is false precision: if the user selects the wrong product version, concentration, or actual injected amount, a tidy incident card may make incorrect information appear credible. Its triage capability would also struggle to compete with free webPOISONCONTROL, which is maintained by toxicology experts. The product must therefore stay focused on information verification and handoff, rather than present itself as a standalone overdose-assessment tool. S2